Time Course and Nature of Nutrient Sensing During Fasting in Humans

July 8, 2011 updated by: Leiden University Medical Center
Several studies have begun to determine the time course of events sensing energy availability in rodents. In contrast, there is not a single study that has examined this in humans to date. A better understanding of this energy sensing machinery in humans is of utmost importance to give us new insights into developing new therapies for common diseases such as obesity, diabetes mellitus, cardiovascular diseases and cancer. In these diseases, disturbances in the energy-sensing machinery possibly play a role. To determine the time course of energy sensing events in humans, the investigators will measure the concentration of various hormones in plasma, and biochemical changes in skeletal muscle at sequential time points during starvation in humans. The investigators choose to study the molecular machinery in muscle, since muscle is very sensitive to fuel deprivation.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zuid-Holland
      • Leiden, Zuid-Holland, Netherlands, 2333ZA
        • Leiden University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 29 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Healthy males
  • Age 19-29 years old
  • Body mass index (BMI) 19-25 kg/m2
  • Stable weight for the last 3 months
  • Caucasian
  • Fasting plasma glucose (FPG) < 6 mmol/L
  • Well-controlled blood pressure (< 150/95 mmHg)
  • Creatinine <100 umol/l
  • Hb > 7.5 mmol/l
  • Negative family history (first degree) of type 2 diabetes mellitus (DM2)

Exclusion Criteria:

  • Use of medication known to affect glucose metabolism (for example prednisone) or lipid metabolism
  • Significant (chronic) disease
  • Smoking (current)
  • Alcohol consumption of more than 14 units per week at present or in the past
  • Difficult accessible veins for insertion of an intravenous catheter
  • Recent blood donation (within the last 3 months)
  • Recent participation in other research projects (within the last 3 months), participation in 2 or more projects in one year
  • Rigorous exercise/sports 5 or more days a week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
healthy young and lean men
48 hours of fasting

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in several proteins/ribonucleic acid (RNA) from muscle biopsies upon fasting
Time Frame: 1.5h, 4h, 10h, 24h
1.5h, 4h, 10h, 24h

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in several hormones, lipids etc. from blood samples upon fasting
Time Frame: 1.5h, 4h, 10h, 24h
1.5h, 4h, 10h, 24h

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hanno Pijl, MD, PhD, Leiden University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

March 1, 2011

Study Completion (Actual)

March 1, 2011

Study Registration Dates

First Submitted

July 1, 2011

First Submitted That Met QC Criteria

July 5, 2011

First Posted (Estimate)

July 6, 2011

Study Record Updates

Last Update Posted (Estimate)

July 11, 2011

Last Update Submitted That Met QC Criteria

July 8, 2011

Last Verified

January 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • P10.164

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prolonged fasting

3
Subscribe